Jupiter Asset Management Ltd. has acquired a new stake of 9,120 shares in Gilead Sciences, Inc. for approximately $1.01 million during the third quarter, contributing to a high institutional ownership of 83.67%. This comes as Gilead reported strong Q4 earnings, beating estimates and providing a positive FY 2026 guidance, leading to several analyst price target increases and a “Moderate Buy” consensus. However, notable insider selling, including by CEO Daniel O’Day and CFO Andrew Dickinson, has occurred, which could potentially pressure investor sentiment.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
9,120 Shares in Gilead Sciences, Inc. $GILD Acquired by Jupiter Asset Management Ltd.
Jupiter Asset Management Ltd. has acquired a new stake of 9,120 shares in Gilead Sciences, Inc. for approximately $1.01 million during the third quarter, contributing to a high institutional ownership of 83.67%. This comes as Gilead reported strong Q4 earnings, beating estimates and providing a positive FY 2026 guidance, leading to several analyst price target increases and a “Moderate Buy” consensus. However, notable insider selling, including by CEO Daniel O’Day and CFO Andrew Dickinson, has occurred, which could potentially pressure investor sentiment.